RE:RE:RE:RE:RE:RE:European expansionnewcoin wrote: I was a professor at the school and I completely agree with Setti. We all know someone who was important at one time in their life. I think the European expansion is fantastic! If you can do it why wouldn't you do it? The company will benefit from his moves.
GunnySackBurlap wrote:
Clap4TheWolfman wrote:
I am still trying to undersatnd the idea of a better "smoke" or mousetrap.To me smoking a cigarette or joint is all about the reward..IE I get high or nicotine rush and I want to do it again or want more.With TAAT its a great idea but what is the reward and the reason to continue to smoke and buy them? If I am polluting my lungs with smoke of any kind I might as well get some satisfaction reward.... I doubt follow through orders ever develop on this product but hope to be proved wrong.
Excellent post C4TWolfman. You just made the point I hinted about earlier but I wanted to give the irrational exhuberance crowd a chance to think of it themselves. Of course they failed that test but you have given them the answer regarding the concept of a reward.
Nicotine for cigarettes and THC for marijuana cigarettes are the reward you posted about. TAAT doesn't have that kind of physical reward all they have is a perceived psychological reward that may not exist for more than a brief period and not long enough to capture a large market share. Basically smokers will try it once and never try it again. So we'll see an initial order spike in each new market followed by stagnant sales. That is why the company is chasing new markets to keep the sales numbers moving higher..
I think your comment about lack of follow through orders will prove to be accurate in the months ahead.
My comments here are in my opinion of course but I did study marketing at the same school where Setti studied so there is always that to think about.
Per Setti, the US market represents only ~3% of the world market. Distribution is well underway. Canada, which has been subbed out to CLC exclusively, presents distribution problems, but only adds another ~1% of the world market, for a North American market share potential of a mere ~4%. Of course the European expansion is a necessary part of the company's strategic plan, as are Australia (huge potential margins), South America, Africa, and Asia, especially China with its ~30% of the world's smokers.
As Setti reminded us recently, marketing the product as a therapy to quit nicotine requires FDA approval of any such beneficial claim. Approval entails trials and testing that TAAT won't be doing, so that will not be a major sales focus for now, though Setti continues talking about it in somewhat guarded terms, just as he has for more than a year now.
PS i don't rely on frogs, Wendy's, or gunny sacks for my information about TAAT. Iggy'd the frog months ago, Wendy soon after she showed her ignorance, and Gunny went today.